Literature DB >> 22590694

Curcumin and curcuminoids in quest for medicinal status.

Grzegorz Grynkiewicz1, Piotr Ślifirski.   

Abstract

Curcumin, known for thousands of years as an Ayurvedic medicine, and popular as a spice in Asian cuisine, has undergone in recent times remarkable transformation into a drug candidate with prospective multipotent therapeutic applications. Characterized by high chemical reactivity, resulting from an extended conjugated double bond system prone to nucleophilic attack, curcumin has been shown to interact with a plethora of molecular targets, in numerous experimental observations based on spectral, physicochemical or biological principles. The collected preclinical pharmacological data support traditional claims concerning the medicinal potential of curcumin and its congeners but at the same time point to their suboptimal properties in the ADME (absorption, distribution, metabolism and excretion) area.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22590694

Source DB:  PubMed          Journal:  Acta Biochim Pol        ISSN: 0001-527X            Impact factor:   2.149


  31 in total

1.  New considerations on hormetic response against oxidative stress.

Authors:  Armando Luna-López; Viridiana Y González-Puertos; Norma E López-Diazguerrero; Mina Königsberg
Journal:  J Cell Commun Signal       Date:  2014-10-05       Impact factor: 5.782

Review 2.  Potential effects of curcumin on peroxisome proliferator-activated receptor-γ in vitro and in vivo.

Authors:  Mohsen Mazidi; Ehsan Karimi; Mohsen Meydani; Majid Ghayour-Mobarhan; Gordon A Ferns
Journal:  World J Methodol       Date:  2016-03-26

3.  Curcumin induces apoptosis in human leukemic cell lines through an IFIT2-dependent pathway.

Authors:  Yonglu Zhang; Yunyuan Kong; Shuyuan Liu; Lingbing Zeng; Lagen Wan; Zhanglin Zhang
Journal:  Cancer Biol Ther       Date:  2017-01-10       Impact factor: 4.742

4.  GRP78 mediates the therapeutic efficacy of curcumin on colon cancer.

Authors:  Yu-Jia Chang; Chien-Yu Huang; Chin-Sheng Hung; Wei-Yu Chen; Po-Li Wei
Journal:  Tumour Biol       Date:  2014-10-04

5.  Curcumin for radiation dermatitis: a randomized, double-blind, placebo-controlled clinical trial of thirty breast cancer patients.

Authors:  Julie L Ryan; Charles E Heckler; Marilyn Ling; Alan Katz; Jacqueline P Williams; Alice P Pentland; Gary R Morrow
Journal:  Radiat Res       Date:  2013-06-07       Impact factor: 2.841

Review 6.  Beneficial Effects of Plant-Derived Natural Products on Non-alcoholic Fatty Liver Disease.

Authors:  Luis E Simental-Mendía; Claudia I Gamboa-Gómez; Fernando Guerrero-Romero; Mario Simental-Mendía; Adriana Sánchez-García; Mariana Rodríguez-Ramírez
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 7.  Curcumin as a potential therapeutic candidate for Helicobacter pylori associated diseases.

Authors:  Avijit Sarkar; Ronita De; Asish K Mukhopadhyay
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

Review 8.  Curcumin and genistein: the combined effects on disease-associated CFTR mutants and their clinical implications.

Authors:  Yoshiro Sohma; Ying-Chun Yu; Tzyh-Chang Hwang
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

9.  Effects of radix curcumae-derived diterpenoid C on Helicobacter pylori-induced inflammation and nuclear factor kappa B signal pathways.

Authors:  Xuan Huang; Bin Lv; Shuo Zhang; Qun Dai; Bing-Bing Chen; Li-Na Meng
Journal:  World J Gastroenterol       Date:  2013-08-21       Impact factor: 5.742

Review 10.  Molecular Pathways: The Balance between Cancer and the Immune System Challenges the Therapeutic Specificity of Targeting Nuclear Factor-κB Signaling for Cancer Treatment.

Authors:  Kristen P Zeligs; Monica K Neuman; Christina M Annunziata
Journal:  Clin Cancer Res       Date:  2016-07-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.